|Mr. Kenneth L. Londoner M.B.A., MBA||Founder, CEO & Exec. Chairman||1.2M||N/A||1968|
|Mr. Steven Chaussy||Chief Financial Officer||N/A||N/A||1954|
|Dr. Budimir S. Drakulic Ph.D.||Chief Scientist||N/A||N/A||1950|
|Ms. Lora Mikolaitis||VP of Admin.||N/A||N/A||1973|
|Mr. Andrew Gornell Ballou||VP of Investor Relations||N/A||N/A||N/A|
|Mr. John M. Kowalski||VP of Sales||N/A||N/A||N/A|
|Mr. Olivier Chaudoir||Sr. Director of Marketing||N/A||N/A||N/A|
|Ms. Brenda Castrodad||Director of HR||N/A||N/A||N/A|
|Ms. Natasha Drapeau||Exec. VP||N/A||N/A||N/A|
|Ms. Julie Stephenson B.S.N., M.B.A.||Sr. Director of Clinical Affairs||N/A||N/A||N/A|
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
BioSig Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.